1. Home
  2. AIR vs KNSA Comparison

AIR vs KNSA Comparison

Compare AIR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AAR Corp.

AIR

AAR Corp.

HOLD

Current Price

$113.14

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$48.54

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIR
KNSA
Founded
1951
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.5B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
AIR
KNSA
Price
$113.14
$48.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$131.20
$60.86
AVG Volume (30 Days)
312.7K
501.4K
Earning Date
03-24-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
225.00
EPS
3.59
0.27
Revenue
N/A
$677,564,000.00
Revenue This Year
$18.83
$37.48
Revenue Next Year
$10.93
$17.87
P/E Ratio
$31.93
$188.52
Revenue Growth
N/A
60.09
52 Week Low
$60.74
$26.27
52 Week High
$127.21
$59.87

Technical Indicators

Market Signals
Indicator
AIR
KNSA
Relative Strength Index (RSI) 52.34 36.64
Support Level $111.65 $40.67
Resistance Level $121.05 $49.57
Average True Range (ATR) 3.95 2.02
MACD 0.71 -1.15
Stochastic Oscillator 65.95 3.18

Price Performance

Historical Comparison
AIR
KNSA

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: